home / Denmark / Novo Nordisk A/S

Novo Nordisk A/S Market Cap

$365.09 B

+14.32 B

OMXCOP:NOVO-B.CO · January 22, 2025

Share price

$82.22

Enterprise Value

$2.536 T

Change (1-Year)

-17.7%

Global Rank

#26

Country Rank

Regions

Denmark

Market cap

As of January 22, 2025, Novo Nordisk A/S (NOVO-B.CO) has a market cap of $365.09 billion USD. According to our data, Novo Nordisk A/S is ranked No.26 in global market value.

Sector Rank:

Biotech #2 Healthcare #2 Pharmaceuticals #2

NOVO-B.CO Market Capitalization Growth

30D Growth:

-7.6%

1 Years Growth:

-17.7%

3 Years Growth:

100.5%

5 Years Growth:

206.0%

10 Years Growth:

390.4%

15 Years Growth:

2156.5%

20 Years Growth:

5866.8%

Total Growth:

4803%

Novo Nordisk A/S Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Novo Nordisk A/S Market Cap CAGR Chart

Novo Nordisk A/S Market Cap History 2001 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$365.09 B	24.46%
Dec 30, 2024	$293.34 B	-9.59%
Dec 29, 2023	$324.47 B	50.74%
Dec 30, 2022	$215.25 B	29.53%
Dec 30, 2021	$166.18 B	75.62%
Dec 30, 2020	$94.62 B	12.77%
Dec 30, 2019	$83.90 B	32.92%
Dec 28, 2018	$63.12 B	-8.60%
Dec 29, 2017	$69.06 B	35.35%
Dec 30, 2016	$51.02 B	-34.55%
Dec 30, 2015	$77.95 B	55.91%
Dec 30, 2014	$50.00 B	33.38%
Dec 30, 2013	$37.48 B	10.55%
Dec 28, 2012	$33.91 B	41.30%
Dec 30, 2011	$24.00 B	6.57%
Dec 30, 2010	$22.52 B	93.29%
Dec 30, 2009	$11.65 B	24.92%
Dec 30, 2008	$9.33 B	-17.97%
Dec 28, 2007	$11.37 B	44.53%
Dec 29, 2006	$7.87 B	34.90%
Dec 30, 2005	$5.83 B	-39.81%
Dec 31, 2004	$9.69 B	26.30%
Dec 31, 2003	$7.67 B	19.45%
Dec 31, 2002	$6.42 B	-39.51%
Dec 31, 2001	$10.62 B	100%

Similar Companies to Novo Nordisk A/S

Name	Market Cap	Market cap difference	Regions
Eli Lilly LLY	$670.90 B	3.292 B	USA
Sanofi SNY	$129.28 B	-0.313 B	France
AstraZeneca AZN	$211.74 B	0.000 M	UK
Bristol-Myers Squibb BMY	$114.88 B	-0.811 B	USA
Merck MRK	$242.90 B	-0.007 M	USA
Pfizer PFE	$149.69 B	-1.275 B	USA
GlaxoSmithKline GSK	$68.73 B	-0.194 B	UK
Johnson & Johnson JNJ	$344.10 B	0.003 M	USA
AbbVie ABBV	$298.08 B	-0.039 B	USA
Amgen AMGN	$147.39 B	-0.333 B	USA
Novo Nordisk NVO	$339.94 B	67.252 B	Denmark
Teva Pharmaceutical Industries TEVA	$24.69 B	-0.037 B	Israel

About Novo Nordisk A/S Inc.

Name

Novo Nordisk B A/S

Website

https://www.novonordisk.com

Headquarters

Bagsvaerd,None

symbol

NOVO-B.CO

CURRENCY

DKK

country

Denmark

fullTimeEmployees

71880

exchange

CPH

firstTradeDateEpochUtc

2001/01/06

NOVO-B.CO Market Cap Formula

Market Cap	=	NOVO-B.CO Stock Price	*	NOVO-B.CO Shares Outstanding
	=	$82.22	*	3.37 B
	=	$365.09 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe